The American Hospital Association has called on federal regulators to intervene after Eli Lilly sent warning letters to 340B hospitals threatening to cut off discounted drug pricing unless they submit ...

The American Hospital Association (AHA) writes to alert you to the latest development in connection with the growing number ...

Despite dramatic expansion over the past 34 years, many rural and underserved hospitals continue to face significant ...

The 340B Drug Pricing Program was established with a clear and crucial objective: to assist safety-net providers in ...

Federal judge permanently blocks North Dakota 340B drug law, ruling it unconstitutional and halting enforcement against drugmakers and PhRMA members.

Idaho Republicans spent the last year as a vanguard for the America First policy agenda, helping President Donald Trump root ...

The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that ...

While it may be hard to believe, there is one issue in Washington that meets the above criteria: fixing the 340B program.

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...

In a move that will fundamentally change how the 340B Drug Pricing Program (“340B Program”) operates for a subset of medications, HRSA’s Office of Pharmacy Affairs (“OPA”) opted late last week to ...

Indiana officials are right to scrutinize how taxpayer dollars are spent, but when it comes to the proposed elimination of the federal 340B drug discount program, the state needs to be cautious. The ...

Tax-exempt hospitals in Minnesota that have raked in large sums of revenue from a government safety net program spent tens of ...